Hospital Universitario Lucus Augusti Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01952223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

H. Lucus Augusti - Lugo | Hospital Lucus Augusti | Hospital Universitario Lucus Augusti

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 3)

Asthma (Phase 4)

Prostatic Neoplasms (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7